** Medical device maker Nevro Corp's shares NVRO.N rise 14.1% to $5.73, while Globus Medical GMED.N shares fall 4.5% to $88.22
** Globus Medical to acquire all shares of Nevro in an all-cash transaction, representing a total equity value of ~$250 million
** Deal offers $5.85 per share for each share of Nevro Corp, a premium of 16.5% to NVRO's last close
** Deal is expected to close late in Q2 2025
** In the last 12 months, GMED up 58.88%, while NVRO has fallen 60.78%
(Reporting by Siddhi Mahatole)
((siddhiprabhanjan.mahatole@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。